RhythMedix announced today that it launched its next-generation RhythmStar wearable device with 4G cellular connectivity.
Mount Laurel, N.J.-based RhythMedix’s next-generation RhythmStar with built-in connectivity is discreetly worn for extended remote monitoring without the need for an additional phone or communication device, according to a news release.
RhythmStar is designed to enable rapid electrocardiogram (ECG) analysis and the reporting of cardiac abnormalities by U.S.-based, certified technicians, who alert physicians if/when a concern is detected. Additionally, RhythmStar is now available with HeartTime, an on-demand telemetry mode allowing physicians to evaluate cardiac activity and expedite care through a telemedicine appointment.
With built-in 4G cellular technology, the one-piece device is touted by RhythMedix as the first wearable, multi-modality cardiac monitor that connects patients and clinicians for improved patient care.
“We are excited to offer physicians and their patients our unique monitoring solution that improves patient compliance, helps accelerate diagnosis, and allows physicians to stay virtually connected to their patients with on-demand access to clinical data”, RhythMedix president, COO & co-founder Brian Pike said in the release. “We look forward to bringing this next-generation RhythmStar technology to physicians across the U.S. in 2021.”